Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Show more...
FAQ
Imunon 今天的股价是多少?▼
CBO0.STU 当前价格为 €1.86 EUR,过去 24 小时上涨了 +1.09%。在图表上更密切关注 Imunon 股价表现。
Imunon 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Imunon 的股票以代码 CBO0.STU 进行交易。
Imunon 下一次财报日期是什么时候?▼
Imunon 将于 八月 06, 2026 发布下一次财报。
Imunon 上一季度的财报怎么样?▼
CBO0.STU 上季度财报为每股 -0.72 EUR,预估为 -1.04 EUR,带来 +30.86% 的意外。下季度预估财报为每股 不适用 EUR。
Imunon 有多少名员工?▼
截至五月 25, 2026,公司共有27名员工。
Imunon 属于哪个行业?▼
Imunon从事于制造业行业。
Imunon 何时完成拆股?▼
Imunon 上次拆股发生在 八月 07, 2025,比例为 1.15:1。
Imunon 的总部在哪里?▼
Imunon 的总部位于 美国 的 Lawrence Township。